Noticias de ARDX_US
Noticias del mercado
Últimas noticias sobre ARDX_US — 546 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Ardelyx recently cut its full-year 2026 IBSRELA revenue guidance to US$350–US$370 million, withdrew a long-term XPHOZAH sales target, filed a US$36 million shelf registration for an ESOP-related common stock offering, and announced the past resignation of Chief Commercial Officer Eric Foster effective August 28, 2026. Together, the lowered guidance, withdrawal of a key revenue goal, and leadership change underscore how payer hurdles are pressuring Ardelyx’s commercial execution and long-term...
Ardelyx recently cut its full-year 2026 IBSRELA revenue guidance to US$350–US$370 million, withdrew a long-term XPHOZAH sales target, filed a US$36 million shelf registration for an ESOP-related common stock offering, and announced the past resignation of Chief Commercial Officer Eric Foster effective August 28, 2026. Together, the lowered guidance, withdrawal of a key revenue goal, and leadership change underscore how payer hurdles are pressuring Ardelyx’s commercial execution and long-term...
Clay Northam Wealth Management LLC purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 334,115 shares of the biopharmaceutical company
Página 19 de 28